Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $19.1250 (-1.92%) ($19.1250 - $19.1250) on Wed. Feb. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.13% (three month average) | RSI | 52 | Latest Price | $19.1250(-1.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.3% a day on average for past five trading days. | Weekly Trend | ATRA advances 0.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.065% in a week (0% probabilities). VIXM(-34%) VXX(-27%) UNG(-10%) UUP(-9%) TLT(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.065% (StdDev 4.13%) | Hourly BBV | -0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $18.98(0.76%) | 10 Day Moving Average | $18.95(0.92%) | 20 Day Moving Average | $19.08(0.24%) | To recent high | -27.3% | To recent low | 45.5% | Market Cap | $1.421b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |